BeyondSpring (NASDAQ:BYSI) PT Lowered to $4.00

BeyondSpring (NASDAQ:BYSI – Get Rating) had its price target decreased by investment analysts at Robert W. Baird from $11.00 to $4.00 in a report released on Wednesday, The Fly reports. Robert W. Baird’s price target suggests a potential upside of 220.00% from the company’s current price.

BeyondSpring Stock Performance

Shares of BYSI opened at $1.25 on Wednesday. The stock has a fifty day moving average price of $2.14 and a two-hundred day moving average price of $1.44. BeyondSpring has a 52-week low of $0.54 and a 52-week high of $3.45. The company has a market cap of $48.66 million, a price-to-earnings ratio of -0.71 and a beta of 0.11.

Institutional Investors Weigh In On BeyondSpring

Several hedge funds and other institutional investors have recently made changes to their positions in the company. BlackRock Inc. increased its stake in shares of BeyondSpring by 20.8% in the 1st quarter. BlackRock Inc. now owns 1,861,219 shares of the company’s stock valued at $4,095,000 after buying an additional 320,428 shares during the period. Millennium Management LLC increased its stake in shares of BeyondSpring by 78.0% in the 2nd quarter. Millennium Management LLC now owns 691,826 shares of the company’s stock valued at $996,000 after buying an additional 303,184 shares during the period. State Street Corp increased its stake in shares of BeyondSpring by 11.5% in the 1st quarter. State Street Corp now owns 563,670 shares of the company’s stock valued at $1,240,000 after buying an additional 57,933 shares during the period. Renaissance Technologies LLC increased its stake in shares of BeyondSpring by 30.0% in the 2nd quarter. Renaissance Technologies LLC now owns 366,959 shares of the company’s stock valued at $528,000 after buying an additional 84,586 shares during the period. Finally, BNP Paribas Arbitrage SA increased its stake in shares of BeyondSpring by 89.6% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 249,308 shares of the company’s stock valued at $359,000 after buying an additional 117,831 shares during the period. 18.14% of the stock is owned by institutional investors and hedge funds.

BeyondSpring Company Profile

(Get Rating)

BeyondSpring, Inc engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the PRC and U.S. geographical segments. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in New York, NY.